Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study
- PMID: 33554490
- DOI: 10.5114/pedm.2020.101003
Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study
Abstract
Introduction: On March 11, 2020 the WHO announced a coronavirus disease 2019 (COVID-19) pandemic. Lockdown restrictions, compromised access to medical care and fear of potential exposure to SARS-CoV-2 have forced patients with non-COVID-19 illnesses such as type 1 diabetes (T1D) to stay home. This situation can lead to delay in T1D diagnosis and insulin treatment resulting in rapid progression to diabetic ketoacidosis (DKA) and therefore increased risk of complications and death. .
Aim: The aim of this study was to evaluate the frequency and severity of DKA at the onset of T1D in children diagnosed in our department during COVID-19 pandemic lockdown from March 2020 till May 2020 in comparison to corresponding period of the previous year. .
Material and methods: We collected data of children with newly diagnosed T1D. DKA was defined according to ISPAD guidelines. .
Results: The study cohort comprised 34 children in group 2020 and 52 in group 2019 with an average age 9.90 ±4.9 vs. 9.59±4.7 years with mean HbA1c 12.9 ±2.4 vs. 11.5 ±2.2%, respectively. The incidence of DKA was higher by 12% in group 2020 vs. 2019 (52.94% vs 40.38%; p = 0.276). Regarding the DKA severity (2020 vs. 2019) 32.35% vs. 11.54% were severe (p = 0.026), 17.65 vs. 13% were moderate (p = 0.759), and 2.94 vs. 15.38% were mild (p = 0.081). None of the analyzed patients were COVID-19 positive.
Conclusions: During the COVID-19 pandemic lockdown changes in society and health care system, the DKA rate has increased by 12 percentage points with more severe cases noted in children with newly diagnosed T1D. Regular education of the whole society about the symptoms of diabetes could contribute to faster diagnosis of T1D and reduction of DKA prevalence. .
Wstęp: Ogłoszona przez WHO w marcu 2020 r. pandemia choroby koronawirusowej 2019 (COVID-19) wpłynęła na wiele aspektów naszego życia. Aktualna sytuacja epidemiologiczna może mieć dodatkowy wpływ na pogłębienie problemów z rozpoznawaniem cukrzycy typu 1 (T1D) i opóźnienie rozpoczęcia leczenia, a w konsekwencji zwiększenia ryzyka rozwoju cukrzycowej kwasicy ketonowej (DKA).
Cel pracy: Ocena i porównanie ciężkości i częstości występowania DKA w okresie od marca do maja 2019 r. oraz w czasie epidemii COVID-19 od marca do maja 2020 r. w grupie dzieci z nowo rozpoznaną cukrzycą.
Materiał i metody: Dokonano analizy przypadków nowo rozpoznanej T1D u dzieci hospitalizowanych na naszym oddziale w analogicznych okresach. Ciężkość DKA była określona w oparciu o definicję ISPAD.
Wyniki: Analizą objęto łącznie 86 dzieci: 34 w grupie z 2020 r. i 52 w grupie z 2019 r. odpowiednio w średnim wieku 9,90 ±4,9 vs 9,59 ±4,7 lat ze średnią HbA1c odpowiednio 12,9 ±2,4 vs 11,5 ±2,2%. W badanym okresie 2020 r. częstość DKA była o 12 punktów procentowych większa w porównaniu z poprzednim rokiem (52,94% vs 40,38%; p = 0,276). Przy przyjęciu (2020 vs 2019) 32,35% vs 11,54% przypadków spełniało kryteria ciężkiej DKA (p = 0,026), 17,65 vs 13% umiarkowanej (p = 0,759) i 2,94 vs 15,38% łagodnej (p = 0,081). U żadnego z analizowanych pacjentów nie rozpoznano COVID-19.
Wnioski: Związana z pandemią COVID-19 zmiana w funkcjonowaniu społeczeństwa i opieki zdrowotnej wpłynęła na wzrost częstości DKA w przebiegu nowo rozpoznanej cukrzycy typu 1 u dzieci o 12 punktów procentowych wraz ze zwiększeniem odsetka ciężkich przypadków. Regularna edukacja całego społeczeństwa o objawach cukrzycy mogłaby wpłynąć na szybsze rozpoznawanie choroby i redukcję częstości DKA.
Keywords: COVID-19.; diabetes mellitus type 1; diabetic ketoacidosis; children.
Similar articles
-
Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis.F1000Res. 2023 Aug 10;12:72. doi: 10.12688/f1000research.128687.2. eCollection 2023. F1000Res. 2023. PMID: 39262444 Free PMC article.
-
Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel.Pediatr Diabetes. 2022 Feb;23(1):10-18. doi: 10.1111/pedi.13296. Epub 2021 Dec 14. Pediatr Diabetes. 2022. PMID: 34865288
-
Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group.Pediatr Diabetes. 2022 Nov;23(7):944-955. doi: 10.1111/pedi.13379. Epub 2022 Jul 4. Pediatr Diabetes. 2022. PMID: 35700323 Free PMC article.
-
Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic.Pediatr Diabetes. 2021 Jun;22(4):552-557. doi: 10.1111/pedi.13205. Epub 2021 Mar 27. Pediatr Diabetes. 2021. PMID: 33745226 Free PMC article.
-
The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.J Med Virol. 2022 Nov;94(11):5112-5127. doi: 10.1002/jmv.27996. Epub 2022 Jul 22. J Med Virol. 2022. PMID: 35831242 Free PMC article.
Cited by
-
Neutrophil-to-Lymphocyte Ratio Adds Valuable Information Regarding the Presence of DKA in Children with New-Onset T1DM.J Clin Med. 2022 Dec 28;12(1):221. doi: 10.3390/jcm12010221. J Clin Med. 2022. PMID: 36615022 Free PMC article.
-
Increase in the Number of Pediatric New-Onset Diabetes and Diabetic Ketoacidosis Cases During the COVID-19 Pandemic.Endocr Pract. 2022 May;28(5):479-485. doi: 10.1016/j.eprac.2022.02.005. Epub 2022 Feb 18. Endocr Pract. 2022. PMID: 35189332 Free PMC article.
-
Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic.Ital J Pediatr. 2022 Feb 9;48(1):26. doi: 10.1186/s13052-022-01223-8. Ital J Pediatr. 2022. PMID: 35139895 Free PMC article.
-
COVID-19 and diabetes in children.Ann Pediatr Endocrinol Metab. 2022 Sep;27(3):157-168. doi: 10.6065/apem.2244150.075. Epub 2022 Sep 30. Ann Pediatr Endocrinol Metab. 2022. PMID: 36203266 Free PMC article.
-
Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis.F1000Res. 2023 Aug 10;12:72. doi: 10.12688/f1000research.128687.2. eCollection 2023. F1000Res. 2023. PMID: 39262444 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous